Exploring Regulatory Affairs, the discipline dedicated to ensuring that new drugs and biologics are safe, effective, and ...

In the evolving landscape of pharmaceutical production, fill-finish contract manufacturing has become a crucial area of focus ...

BioPlan Associates presents research and projections on the pharma sterile fill-finish industry’s future over the next 10 ...

Navigating the sterile outsourcing bottleneck and how CDMOs must adapt to meet the growing demand for small-batch biologics and flexible fill-finish solutions. The sterile outsourcing industry is at a ...